Phil Leighton
About Phil Leighton
Phil Leighton serves as the Director of Molecular Biology at Ligand Pharmaceuticals in Emeryville, California, a position he has held since 2017. He has a strong academic background with a Ph.D. in Molecular Biology from Princeton University and has previously worked at UCSF and Repligen Corporation.
Current Role at Ligand Pharmaceuticals
Phil Leighton serves as the Director of Molecular Biology at Ligand Pharmaceuticals, a position he has held since 2017. In this role, he oversees molecular biology initiatives and contributes to the company's research and development efforts. Ligand Pharmaceuticals is located in Emeryville, California, and focuses on advancing innovative therapies through its proprietary technologies.
Previous Experience at UCSF
Before joining Ligand Pharmaceuticals, Phil Leighton worked as a Postdoctoral Fellow at the University of California, San Francisco (UCSF) from 1995 to 2001. During his six years at UCSF, he engaged in advanced research in molecular biology, contributing to the academic community and enhancing his expertise in the field.
Educational Background
Phil Leighton earned his Bachelor's Degree in Biological Sciences from Stanford University, where he studied from 1983 to 1987. He furthered his education at Princeton University, obtaining a Doctor of Philosophy (Ph.D.) in Molecular Biology after six years of study from 1989 to 1995. His educational background provides a strong foundation for his career in molecular biology.
Early Career at Repligen Corporation
Phil Leighton began his career as a Research Technician at Repligen Corporation in Cambridge, Massachusetts, where he worked for one year from 1988 to 1989. This early experience in a research environment contributed to his development in the field of molecular biology and set the stage for his subsequent academic and professional achievements.